116
Views
36
CrossRef citations to date
0
Altmetric
Original Research

Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice

, , , , , & show all
Pages 1065-1079 | Published online: 31 Mar 2017

References

  • ShiYHuFBThe global implications of diabetes and cancerLancet20143839933 1947 194824910221
  • KanwarYSSunLXiePLiuFYChenSA glimpse of various patho-genetic mechanisms of diabetic nephropathyAnnu Rev Pathol20116 395 42321261520
  • MotawiTKAhmedSAHamedMAElmaraghySAAzizWMCombination of melatonin and certain drugs for treatment of diabetic nephropathy in streptozotocin-induced diabetes in ratsDiabetol Int201674 413 424
  • HeJXuYKoyaDKanasakiKRole of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney diseaseClin Exp Nephrol2013174 488 49723430391
  • PowellDWBertramCCCumminsTDRenal tubulointerstitial fibrosis in OVE26 type 1 diabetic miceNephron Exe Nephrol20081111 e11 e19
  • MorrisseyJGuoGMoridairaKTransforming growth factor-beta induces renal epithelial jagged-1 expression in fibrotic diseaseJ Am Soc Nephrol2002136 1499 150812039979
  • MureaMParkJKSharmaSExpression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal functionKidney Int2010785 514 52220531454
  • SharmaSSirinYSusztakKThe story of Notch and chronic kidney diseaseCurr Opin Nephrol Hypertens2011201 56 6121088575
  • BieleszBSirinYSiHEpithelial notch signaling regulates interstitial fibrosis development in the kidneys of mice and humansJ Clin Invest201012011 4040 405420978353
  • BonegioRSusztakKNotch signaling in diabetic nephropathyExp Cell Res20123189 986 99222414874
  • KatohMKatohMComparative genomics on SNAI1, SNAI2, and SNAI3 orthologsOncol Rep2005144 1083 108616142376
  • PaznekasWAOkajimaKSchertzerMWoodSJabsEWGenomic organization, expression, and chromosome location of the human SNAIL gene (SNAI1) and a related processed pseudogene (SNAI1P)Genomics1999621 42 4910585766
  • PeinadoHBallestarEEstellerMCanoASnail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complexMol Cell Biol2004241 306 31914673164
  • HerranzNPasiniDDiazVMPolycomb complex 2 is required for E-cadherin repression by the Snail1 transcription factorMol Cell Biol20082815 4772 478118519590
  • MatsunoYCoelhoALJaraiGWestwickJHogaboamCMNotch signaling mediates TGF-beta1-induced epithelial-mesenchymal transition through the induction of Snai1Int J Biochem Cell Biol2012445 776 78922330899
  • TuttleKRBakrisGLTotoRDMcGillJBHuKAndersonPWThe effect of ruboxistaurin on nephropathy in type 2 diabetesDiabetes Care20052811 2686 269016249540
  • MannJFGreenDJamersonKAvosentan for overt diabetic nephropathyJ Am Soc Nephrol2010213 527 53520167702
  • PazdroRBurgessJRThe role of vitamin E and oxidative stress in diabetes complicationsMech Ageing Dev20101314 276 28620307566
  • JinHPiaoSGJinJZSynergistic effects of leflunomide and benazepril in streptozotocin-induced diabetic nephropathyNephron Exp Nephrol20141263 148 15624855017
  • ToneAShikataKSasakiMErythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic ratsDiabetologia20054811 2402 241116231067
  • LengSHLuFEXuLJTherapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretionActa Pharmacol Sin2004254 496 50215066220
  • DomitrovicRCvijanovicOPernjak-PugelESkodaMMikelicLCrncevic-OrlicZBerberine exerts nephroprotective effect against cisplatin-induced kidney damage through inhibition of oxidative/nitrosative stress, inflammation, autophagy and apoptosisFood Chem Toxicol201362 397 40624025684
  • ZhangMLvXLiJSodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesisMol Cell Endocrinol20123631–2 122 13022922125
  • ZhangYPengFGaoBIngramAJKrepinskyJCHigh glucose-induced RhoA activation requires caveolae and PKCbeta1-mediated ROS generationAm J Physiol Renal Physiol20123021 F159 F17221975875
  • WangFLTangLQYangFZhuLNCaiMWeiWRenoprotective effects of berberine and its possible molecular mechanisms in combination of high-fat diet and low-dose streptozotocin-induced diabetic ratsMol Biol Rep2013403 2405 241823196710
  • ZhangXHeHLiangDProtective effects of berberine on renal injury in streptozotocin (STZ)-induced diabetic miceInt J Mol Sci2016178 E132727529235
  • LanTLiuWXieXBerberine suppresses high glucose-induced TGF-beta1 and fibronectin synthesis in mesangial cells through inhibition of sphingosine kinase 1/AP-1 pathwayEur J Pharmacol20126971–3 165 17223085271
  • JiangQLiuPWuXBerberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-kappaB signaling pathwayMol Cell Endocrinol20113311 34 4020674665
  • LiuWTangFDengYBerberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose conditionMol Cell Biochem20093251–2 99 10519142714
  • LiuWZhangXLiuPEffects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injuryEur J Pharmacol20106381–3 150 15520447389
  • YuWShengMXuRBerberine protects human renal proximal tubular cells from hypoxia/reoxygenation injury via inhibiting endoplasmic reticulum and mitochondrial stress pathwaysJ Transl Med2013111 2423360542
  • McCrightBNotch signaling in kidney developmentCurr Opin Nephrol Hypertens2003121 5 1012496659
  • OlmedaDJordaMPeinadoHFabraACanoASnail silencing effectively suppresses tumour growth and invasivenessOncogene20072613 1862 187417043660
  • SumualSSaadSTangODifferential regulation of Snail by hypoxia and hyperglycemia in human proximal tubule cellsInt J Biochem Cell Biol20104210 1689 169720620220
  • JiaWTongNDiabetes prevention and continuing health-care reform in ChinaLancet Diabetes Endocrinol2015311 840 84226496828
  • FaragYMAl WakeelJSDiabetic nephropathy in the Arab Gulf countriesNephron Clin Pract20111194 c317 c322 discussion c322–c31322123454
  • LowWYLeeYKSamyALNon-communicable diseases in the Asia-Pacific region: prevalence, risk factors and community-based preventionInt J Occup Med Environ Health2015281 20 2626159943
  • SunGDLiCYCuiWPReview of herbal traditional Chinese medicine for the treatment of diabetic nephropathyJ Diabetes Res20162016 574985726649322
  • IwatsukaHShinoASuzuokiZGeneral survey of diabetic features of yellow KK miceEndocrinol Jpn1970171 23 355468422
  • BazhanNMMakarovaENThe effect of the “yellow” mutation at the mouse agouti locus on the hormonal profile of pregnancy and lactationRoss Fiziol Zh Im I M Sechenova20099511 1254 125720058824
  • HerbergLColemanDLLaboratory animals exhibiting obesity and diabetes syndromesMetabolism1977261 59 99834144
  • TongXLDongLChenLZhenZTreatment of diabetes using traditional Chinese medicine: past, present and futureAm J Chin Med2012405 877 88622928822
  • ShiXLuXGZhanLBThe effects of the Chinese medicine ZiBu PiYin recipe on the hippocampus in a rat model of diabetes-associated cognitive decline: a proteomic analysisDiabetologia2011547 1888 189921509442
  • ZhaoHLSuiYQiaoCFSustained antidiabetic effects of a berberine-containing Chinese herbal medicine through regulation of hepatic gene expressionDiabetes2012614 933 94322396199
  • WenXZengYLiuLZhenqing recipe alleviates diabetic nephropathy in experimental type 2 diabetic rats through suppression of SREBP-1cJ Ethnopharmacol20121421 144 15022564814
  • XiaoYLiuYYuKThe effect of Chinese herbal medicine on albuminuria levels in patients with diabetic nephropathy: a systematic review and meta-analysisEvid Based Complement Alternat Med20132013 93754924062795
  • PirilloACatapanoALBerberine, a plant alkaloid with lipid- and glucose-lowering properties: from in vitro evidence to clinical studiesAtherosclerosis20152432 449 46126520899
  • TillhonMGuaman OrtizLMLombardiPScovassiAIBerberine: new perspectives for old remediesBiochem Pharmacol20128410 1260 126722842630
  • YaoJKongWJiangJLearning from berberine: treating chronic diseases through multiple targetsSci China Life Sci2015589 854 85924174332
  • RussellSBRussellJDTrupinKMEpigenetically altered wound healing in keloid fibroblastsJ Invest Dermatol201013010 2489 249620555348
  • SassoliCChelliniFPiniARelaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-beta/Smad3 signalingPLoS One201385 e6389623704950
  • ChuangPYMenonMCHeJCMolecular targets for treatment of kidney fibrosisJ Mol Med (Berl)2013915 549 55923179685
  • KalluriRWeinbergRAThe basics of epithelial-mesenchymal transitionJ Clin Invest20091196 1420 142819487818
  • GrandeMTSanchez-LaordenBLopez-BlauCSnail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established diseaseNat Med2015219 989 99726236989
  • LovisaSLeBleuVSTampeBEpithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosisNat Med2015219 998 100926236991
  • SaadSStannersSRYongRTangOPollockCANotch mediated epithelial to mesenchymal transformation is associated with increased expression of the Snail transcription factorInt J Biochem Cell Biol2010427 1115 112220348013